The Protective Efficacy of Single-Dose Nasal Immunization with Cold-Adapted Live-Attenuated MERS-CoV Vaccine against Lethal MERS-CoV Infections in Mice

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe diseases in humans. Camels act as intermediate hosts for MERS-CoV. Currently, no licensed vaccine is available for this virus. We have developed a potential candidate vaccine for MERS-CoV using the cold adaptation method. We culti...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Heejeong, Jang, Yunyueng, Kwak, Dongmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459767/
https://www.ncbi.nlm.nih.gov/pubmed/37631921
http://dx.doi.org/10.3390/vaccines11081353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459767/
https://www.ncbi.nlm.nih.gov/pubmed/37631921
http://dx.doi.org/10.3390/vaccines11081353

Ejemplares similares